Andrasic Petra, Zrinski Topic Renata, Pavic Ivan, Lenicek Krleza Jasna
Department of Medical Biochemistry and Hematology, Children's Hospital Zagreb, Zagreb, Croatia.
Department of Pulmonology, Allergology, Immunology and Rheumatology, Children's Hospital Zagreb, Zagreb, Croatia.
Biochem Med (Zagreb). 2025 Feb 15;35(1):011002. doi: 10.11613/BM.2025.011002. Epub 2024 Dec 15.
Ceftriaxone, a widely used antibiotic, is one of the most common drugs to cause drug-induced immune hemolytic anemia. In this report, we describe the effect of ceftriaxone on red blood cell parameters (low red blood cell count, low hematocrit, and high erythrocyte index values) in two pediatric patients without clinical symptoms of hemolytic anemia. Although automated hematology analyzers have helped to detect incorrect results, a peripheral blood smear examination was necessary for recognizing the erythrocyte agglutinins caused by ceftriaxone. Serological testing was not possible, but the resulting drug-induced antibodies mimicked cold agglutinins in the first patient and warm agglutinins in the second patient. Timely reactions and corresponding laboratory procedures prevented potential complications due to drug administration. This report aims to present laboratory findings and preanalytical challenges in these cases and share our experiences in solving them.
头孢曲松是一种广泛使用的抗生素,是导致药物性免疫性溶血性贫血最常见的药物之一。在本报告中,我们描述了头孢曲松对两名无溶血性贫血临床症状的儿科患者红细胞参数(红细胞计数低、血细胞比容低和红细胞指数值高)的影响。尽管自动血液分析仪有助于检测错误结果,但外周血涂片检查对于识别由头孢曲松引起的红细胞凝集素是必要的。血清学检测无法进行,但产生的药物诱导抗体在第一例患者中模拟冷凝集素,在第二例患者中模拟温凝集素。及时的反应和相应的实验室程序预防了因给药引起的潜在并发症。本报告旨在介绍这些病例的实验室检查结果和分析前面临的挑战,并分享我们解决这些问题的经验。